The World Health Organization (WHO) defines overweight as a body mass index (BMI) greater than 25 and less than 29.9 kg/m 2 and obesity as a BMI of 30 kg/m 2 or greater.
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or greater. 1 Epidemiological data report an increasing prevalence of obesity in the past 20 years, which has become pandemic in several countries especially in the Western world. 2 Despite the clear association of obesity with mortality, it is still unclear if body weight is an independent risk factor as it is often linked with other variables including hypertension, smoking, diabetes mellitus and physical inactivity, which all may be sources of morbidity and predict a poor outcome. 3, 4 Obesity and increased body weight are most feared for their deleterious impact on cardiovascular health. Obesity may promote the development of premature coronary artery disease even in young individuals, 5 as well as cardiac remodelling with left ventricular hypertrophy and left atrial enlargement resulting in heart failure and atrial fibrillation. 6, 7 Although in obese patients progressive heart failure and acute myocardial infarction are common causes of death, an increased electrical irritability mediated by non-atherosclerotic pathways such as alterations in left ventricular structure and autonomic nervous system modulation may be the cause of ventricular arrhythmias and sudden death. In the Framingham Heart Study obese individuals had a risk of sudden death 40 times higher than non-obese individuals. 8 However, the relationship between BMI and outcome is not fully understood as there is increasing evidence that patients, with chronic diseases and elevated BMI, may demonstrate lower all-cause and cardiovascular mortality compared with patients of normal weight. This protective effect of obesity has been described as the 'obesity paradox'. 9 In epidemiological studies, BMI is frequently used as a surrogate for the assessment of excess body fat. However, BMI is a crude anthropometric parameter that does not account for the fat mass/fat-free mass ratio and body fat distribution, possibly resulting in a flawed assessment of cardiovascular risk. Therefore, one of the main still unanswered questions is what is the best anthropometric biomarker that summarises the complexity of nutritional status and body fat composition. Do we have reliable means to identify body fat percentage and can we do it in an easy and costeffective way?
In this issue of the European Journal of Preventive Cardiology, Byambasukh et al. 10 try to answer this question using bioelectrical impedance analysis (BIA) as a prognostic tool in a cohort of 6486 subjects enrolled in the Prevention of Renal and Vascular End-stage Disease (PREVEND) study. Bioelectrical impedance analysis may be particularly attractive as it is a non-invasive, feasible technique for estimating body composition. However, several equations for calculation of the body fat percentage through BIA have been proposed, possibly leading to different results in terms of outcome. The authors used a combined endpoint analysis which included cardiovascular mortality and cardiovascular morbidity taking into account a wide spectrum of cardiovascular events. They tested the prognostic value of each BIA equation and interestingly showed that most of the BIA equations have a significantly stronger power to predict outcome than BMI and waist circumference.
The study conveys important messages pertinent to the prognostic value of body fat percentage. The assessment of BMI and waist circumference does not tell the whole truth about cardiovascular risk. Bioelectrical impedance analysis gives us the opportunity to measure the body fat percentage accurately with relevant clinical implications for diet counselling and lifestyle management.
Although the study investigates longitudinally an impressively large cohort reaching meaningful results, some limitations should be acknowledged.
The authors used a combined endpoint which includes cardiovascular morbidity and mortality. Cardiovascular morbidity outcomes included both ischaemic and haemorrhagic events (such as subarachnoid haemorrhage, intracerebral haemorrhage and other intracranial haemorrhages) as well as vascular interventions. This is a wide spectrum of events and the association with measures of body weight and body fat percentage is possibly driven by specific outcomes in which the prognostic power of superfluous adipose tissue is indeed likely to be deleterious. While the biological link between body fat and acute myocardial infarction, coronary or peripheral artery disease and related catheter-based or surgical interventions is strong, the same cannot be said for bleeding events. It is possible therefore that the assessment of a cumulative endpoint including such a broad spectrum of outcomes may be flawed, as measures of adiposity are likely to impact selectively on certain events and not on others.
The role of adipose tissue in the development of atherosclerosis is well established, and a plethora of mechanisms, including endothelial dysfunction, inflammation, insulin resistance and oxidative stress are involved. 11 The mechanistic link between obesity and atherosclerosis translates meaningfully in observational studies that showed a high prevalence of atherosclerotic coronary artery disease in obese individuals (both at autopsy and at computed tomography). 12, 13 Most of these studies relied on BMI and waist circumference, and future studies should investigate whether atherosclerosis and body fat percentage measured through BIA are independently associated.
In summary, the current study provides significant insights into the relationship of body fat percentage measured through BIA and cardiovascular risk. Crude anthropometric measures such as BMI and waist circumference are likely to fail in predicting outcome, as they are a poor reflection of biological and nutritional status. The protective effect of obesity described as the 'obesity paradox' may be simply due to our inability to measure adiposity accurately. Bioelectrical impedance analysis appears to be a reliable and feasible tool that provides answers in this regard and may contribute significantly to a more accurate risk stratification.
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